Created in 1979 by the healthcare technology industry, Medmarc's mission is to be the superior provider of liability insurance protection and related risk management solutions to the life sciences and medical technology industry. We support the development, testing, and delivery of medical products that save lives and improve the quality of life. Through collaboration with our parent company, ProAssurance, and our strategic alliance carriers in the U.S. and abroad, we provide innovative healthcare liability insurance solutions to the life sciences companies we serve. From ideas and prototypes to the reality of commercialization and success - We Can Meet Your Changing Needs. Contact us to discuss your life sciences insurance coverage and what coverages are needed for your business.
(703) 652-1360
Products Liability
Clinical Trials
Errors & Omissions
All Divisions
Subscribe to Medmarc's News and Resources
Upcoming Medtech and Life Sciences Events
-
Annual Partnering Forum At JPM Healthcare Week
CSSi LifeSciences™ along with MTEC (Medical Technology Enterprise Consortium) will host the annual Partnering Forum during the JP Morgan Healthcare Conference at the Hilton San Francisco Union Square hotel this January 2025 and online in February 2025.Register for Annual Partnering Forum At JPM Healthcare Week Read More about Annual Partnering Forum At JPM Healthcare Week -
RESI JPM 2025 San Fran
This RESI is held concurrently with JP Morgan Healthcare Week which will take place from January 13-16, 2025, at the Westin St. Francis in San Francisco.Register for RESI JPM 2025 San Fran Read More about RESI JPM 2025 San Fran -
LSI USA '25
Partner with the Leaders Building Medtech.Register for LSI USA '25 Read More about LSI USA '25 -
Innovation Summit Dublin 2025
Join Medmarc in Dublin for the 2025 Innovation Summit!Register for Innovation Summit Dublin 2025 Read More about Innovation Summit Dublin 2025
Latest Medtech and Life Sciences Blog Posts
-
FDA Stands Its Ground on CDS Guidance
The FDA’s guidance for clinical decision support (CDS) programs has proven unusually controversial, ... -
FDA Finalizes Guidance for AI Predetermined Change Control Plans
The FDA has published the final version of a guidance for predetermined change control plans (PCCPs)... -
FDA Appoints New Director for Center for Devices
The FDA has appointed a new director for the Center for Devices and Radiological Health (CDRH) to re...